S

Sanbo Hospital Management Group Ltd
SZSE:301293

Watchlist Manager
Sanbo Hospital Management Group Ltd
SZSE:301293
Watchlist
Price: 44.01 CNY -6% Market Closed
Market Cap: 9.1B CNY
Have any thoughts about
Sanbo Hospital Management Group Ltd?
Write Note

Sanbo Hospital Management Group Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sanbo Hospital Management Group Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Net Change in Cash
ÂĄ221.7m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Net Change in Cash
-ÂĄ304m
CAGR 3-Years
-232%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Net Change in Cash
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-83%
Hengkang Medical Group Co Ltd
SZSE:002219
Net Change in Cash
-ÂĄ250.6m
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
-11%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Net Change in Cash
-ÂĄ359.4m
CAGR 3-Years
N/A
CAGR 5-Years
20%
CAGR 10-Years
-1%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Net Change in Cash
ÂĄ2.6B
CAGR 3-Years
154%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
9.1B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd. engages in the provision of neurosurgery medical service. The company is headquartered in Beijing, Beijing and currently employs 1,733 full-time employees. The company went IPO on 2023-05-05. The firm is principally engaged in the operation of neurospecialty hospitals. The firm is also engaged in general hospital operations. The firm's diagnostic and treatment programs include neurosurgery, neurointervention, neurology, neuro-oncology chemotherapy, neuro-oncology radiotherapy, neurocritical care and other diagnostic and treatment programs. The other diagnostic and treatment programs include surgery, internal medicine, obstetrics and gynecology, pediatrics, emergency department, imaging department, laboratory department and others. The firm primarily operates its businesses in the domestic market.

Intrinsic Value
24.48 CNY
Overvaluation 44%
Intrinsic Value
Price
S

See Also

What is Sanbo Hospital Management Group Ltd's Net Change in Cash?
Net Change in Cash
221.7m CNY

Based on the financial report for Dec 31, 2023, Sanbo Hospital Management Group Ltd's Net Change in Cash amounts to 221.7m CNY.

What is Sanbo Hospital Management Group Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
24%

Over the last year, the Net Change in Cash growth was 106%. The average annual Net Change in Cash growth rates for Sanbo Hospital Management Group Ltd have been 24% over the past three years .

Back to Top